University Of California, San Diego
Clinical trials sponsored by University Of California, San Diego, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A new strategy aims to plug gaps in HIV care for people who inject drugs Results expected Sep 2026 (estimated)
- Mentoring dads: a new way to stop violence and boost child development? Results expected Sep 2026 (estimated)
- Can online peer support help women with HIV and trauma stay on track? Results expected Sep 2026 (estimated)
- Mailed cancer tests battle: which stool test screens better for colon cancer? Results expected Sep 2026 (estimated)
- AI chatbot aims to ease postpartum loneliness and boost pelvic floor health Results expected Oct 2026 (estimated)
-
Promising combo therapy for head and neck cancer hits early snag
Disease control Stopped earlyThis phase II trial tested two drug combinations—ibrutinib plus nivolumab or ibrutinib plus cetuximab—in patients with recurrent or metastatic head and neck squamous cell carcinoma. The goal was to see if these combinations could shrink tumors or slow disease progression. However…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New transplant method shows promise for tough blood cancers
Disease control Stopped earlyThis study tested a bone marrow transplant using a partially matched family donor for people with blood cancers like leukemia. The goal was to see if a milder conditioning regimen and a drug called cyclophosphamide could help patients survive at least 180 days after transplant. T…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug cocktail shows promise for Tough-to-Treat myeloma
Disease control Stopped earlyThis study tested a combination of four drugs (daratumumab, ixazomib, pomalidomide, and dexamethasone) in 23 people with multiple myeloma that had come back or stopped responding to earlier treatments. The goal was to see how many patients' tumors shrank or disappeared. The study…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
CBD shows promise for emotional health in HIV patients
Symptom relief Stopped earlyThis study tested whether synthetic cannabidiol (CBD) could help people living with HIV who have a condition called alexithymia, which makes it hard to recognize and describe emotions. Participants took either CBD or a placebo for 4 weeks. The goal was to see if CBD could improve…
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Could zapping the brain help treat anorexia?
Symptom relief Stopped earlyThis study tests whether a non-invasive brain stimulation technique called TMS can help people with anorexia nervosa. The treatment targets the insula, a brain region involved in taste and body perception. Forty women aged 18-45 with anorexia will receive either real or sham TMS …
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC